{"result": {"id": "chatcmpl-70", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "## Choroidal Neovascularization (CNV)\n\nChoroidal neovascularization (CNV) is a rare, sight-threatening condition affecting the eyes characterized by abnormal blood vessel growth in the choroid or cornea.  It can manifest as either corneal neovascularization, where new blood vessels form on the cornea, or choroidal neovascularization, which involves abnormal blood vessel growth in the choroid. CNV is a subtype of exudative age-related macular degeneration (AMD) and can be studied for treatment options, including those targeting HRMECs (hyperreflective micro-vessels). \n\nCNV is often diagnosed through optical coherence tomography (OCT) imaging and can influence injection intervals in certain conditions.  It is also a type of genetic variation that can affect cell viability and proliferation, potentially leading to tissue damage. Research on CNV has been conducted using various methods, including slit lamp microscopy and laser-induced CNV formation in mice models. The clinical phenotype of CNV in AMD provides valuable insights into the condition's progression and impact on vision. Genetic variation associated with CNV can be suppressed using CRISPR-Cas9 technology. \n\n\nWhile CNV is a rare condition, it can lead to complications such as blindness caused by corneal neovascularization.  It can also be related to other conditions like cataracts and corneal fibrosis.  CNV can impair corneal transparency and visual acuity, leading to decreased vision. It's important to note that CNV can occur more often than expected, but this condition is not always present in a clinical setting. Additionally, the presence of sub-clinical CNVs (adjacent to hyperpigmented areas) suggests a potential for future complications. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743288520, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 344, "prompt_tokens": 588, "total_tokens": 932, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"CNV\"\nDescription List: [\"## Choroidal Neovascularization (CNV)\\n\\nChoroidal neovascularization (CNV) is a condition that causes abnormal blood vessel growth in the eye. This process, often referred to as \\\"neovascularization,\\\" can lead to various complications, including blindness caused by corneal neovascularization.  CNV is a type of eye condition and a disease or condition being treated by EGF's nanomedicine. \\n\\nIt is important to note that CNV can be related to other conditions such as cataracts and corneal fibrosis. The process of CNV can also be studied using models like the laser-induced CNV model, which helps researchers understand age-related macular degeneration.  CNV can impair corneal transparency and visual acuity, leading to decreased vision. \\n\\nWhile some descriptions mention CNV occurring more often than expected, it's important to remember that this condition is not always present in a clinical setting. Additionally, the presence of sub-clinical CNVs (adjacent to hyperpigmented areas) suggests a potential for future complications.  \\n\", \"**Choroidal neovascularization (CNV)** is a rare, sight-threatening condition affecting the eyes characterized by abnormal blood vessel growth in the choroid or cornea.  It can manifest as either corneal neovascularization, where new blood vessels form on the cornea, or choroidal neovascularization, which involves abnormal blood vessel growth in the choroid. CNV is a subtype of exudative age-related macular degeneration (AMD) and can be studied for treatment options, including those targeting HRMECs (hyperreflective micro-vessels).  CNV is often diagnosed through optical coherence tomography (OCT) imaging and can influence injection intervals in certain conditions. It is also a type of genetic variation that can affect cell viability and proliferation, potentially leading to tissue damage. Research on CNV has been conducted using various methods, including slit lamp microscopy and laser-induced CNV formation in mice models.  The clinical phenotype of CNV in AMD provides valuable insights into the condition's progression and impact on vision. Genetic variation associated with CNV can be suppressed using CRISPR-Cas9 technology. \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_967a5a9fa0661a351903a38c7d5cd50dd9a72214901954600a890806d32bbd8b_v2"}